Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility

By Foresta C.   Bettella A.   Merico M.   Garolla A.   Ferlin A.   Rossato M.  

Fertility and Sterility, Vol. 77, Iss. 2, 2002-02 ,pp. : 238-244

Elsevier

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Body Mass Index, Follicle-Stimulating Hormone and Their Predictive Value in In Vitro Fertilization

By Ferlitsch Kathrin   Sator Michael   Gruber Doris   Rücklinger Ernst   Gruber Christian   Huber Johannes  

Journal of Assisted Reproduction and Genetics, Vol. 21, Iss. 12, 2004-12 ,pp. : 431-436

Springer Publishing Company

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite

Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization

By Chuang C.-C.   Chen C.-D.   Chao K.-H.   Chen S.-U.   Ho H.-N.   Yang Y.u.-S.  

Fertility and Sterility, Vol. 79, Iss. 1, 2003-01 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite